Fluvoxamine Related Clinical Trials
The Effect of Fluvoxamine on Polysonogram in Depressed Patients With Insomnia [Recruiting]
Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers [Completed]
Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor [Terminated]
Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine [Completed]
Impact of Omeprazole and Fluvoxamine on Platelet Response to Clopidogrel [Completed]
Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel [Completed]
Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents [Completed]
Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents [Terminated]
Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine [Completed]
Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood? [Completed]
A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy Volunteers [Completed]
Interaction Between Fluvoxamine and Sildenafil [Completed]
Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine [Completed]
A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects [Completed]
Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes [Recruiting]
A Phase 3 Study of SME3110 in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder [Active, not recruiting]
FevarinŽ Effectiveness in Treatment of Depression in Patients With Neurological Disorder [Active, not recruiting]
Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) [Not yet recruiting]
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors. [Completed]
Treatment for Anxiety in Children [Completed]
Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury [Completed]
Algorithm Guided Treatment Strategies for Major Depressive Disorder [Recruiting]
Interpersonal Psychotherapy for Treatment Resistant Depression [Recruiting]
AV650 Drug-Drug Interaction Study [Completed]
Treatment of Youth With ADHD and Anxiety [Completed]
Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications [Recruiting]
Treatment of Obsessive-Compulsive Disorder [Completed]
Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder [Recruiting]
Pharmacovigilance in Gerontopsychiatric Patients [Recruiting]
The Gut Microbiota in Obsessive-Compulsive Disorder [Recruiting]
Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression [Completed]
Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot [Completed]
Treatment of Obsessive Compulsive Disorder in Children [Completed]
Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder [Completed]
The Establishment of the Objective Diagnostic Markers and Personalized Medical Intervention in Patients With Major Depressive Disorders (MDD) [Not yet recruiting]
YouScript IMPACT Registry [Active, not recruiting]
Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder. [Completed]
Platelet Function in Patients Treated With SSRI and Non-SSRI Antidepressants [Completed]
Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease [Terminated]
Pharmacogenetic Study of Obsessive-Compulsive Disorder [Recruiting]
Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study [Withdrawn]
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism [Completed]
Lexapro and Pramipexole and to Treat Major Depression [Completed]
|
